Regan McFaul, APRN
Women's Health · Austin, TXNPI 1871195156
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 173 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 31.2% of the total. Among women's health clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 173 payments — averaging $14.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$789
- Biogen$176
- Hologic Sales And Service, LLC$167
- Exeltis, USA Inc.$162
- Mayne Pharma Commercial LLC$160
- Organon$150
- plus $927 from 21 others
What the payments were for
- Food & beverage$2,532100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 82 | $789 |
| Biogen | 11 | $176 |
| Hologic Sales And Service, LLC | 8 | $167 |
| Exeltis, USA Inc. | 10 | $162 |
| Mayne Pharma Commercial LLC | 7 | $160 |
| Organon | 7 | $150 |
| Coopersurgical, Inc. | 7 | $122 |
| Evofem Biosciences, Inc. | 6 | $118 |
| Agile Therapeutics, Inc. | 7 | $115 |
| Astellas Pharma US Inc | 6 | $102 |
| Axonics, Inc. | 1 | $97 |
| Myovant Sciences Inc. | 3 | $63 |
| Acella Pharmaceuticals, LLC | 2 | $40 |
| Pfizer | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Bausch Health US, LLC | 1 | $19 |
| Millicent US Inc | 1 | $18 |
| Merck | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Bayer | 1 | $17 |
| IBSA Pharma Inc. | 1 | $17 |
| Exact Sciences | 1 | $15 |
| Minerva Surgical, Inc | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Davol Inc. | 1 | $14 |
| Ascend Therapeutics US, LLC | 1 | $13 |
How this compares
$2,532 in reported general payments places this provider in the 90th percentile of 609 women's health providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 13 | $667 |
| ProgesteroneProgesterone, Micronized | 13 | $543 |
Paid to pharmacies, not to this prescriber.
Other women's health in Austin
- Amanda ArmondAustin$17K
- Casey FriesenhahnAustin$5K
- Kelly ReaganAustin$4K
- Madison WebbAustin$4K
- Gretchen PalmerAustin$3K
- Jenna CarneyAustin$3K
- Evelyn TingGrapevine$89K
- Christina TrumanWaco$70K
- Kayla CastanedaEl Paso$53K
- Shelagh LarsonFort Worth$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.